Boosting the Brain Delivery of Atazanavir through Nanostructured Lipid Carrier-Based Approach for Mitigating NeuroAIDS

Atazanavir (ATZ) presents poor brain availability when administered orally, which poses a major hurdle in its use as an effective therapy for the management of NeuroAIDS. The utilization of nanostructured lipid carriers (NLCs) in conjunction with the premeditated use of excipients can be a potential...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmaceutics
Main Authors: Khan, Saif Ahmad, Rehman, Saleha, Nabi, Bushra, Iqubal, Ashif, Nehal, Nida, Fahmy, Usama A., Kotta, Sabna, Baboota, Sanjula, Md, Shadab, Ali, Javed
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694775/
https://ncbi.nlm.nih.gov/pubmed/33172119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics12111059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados